April 24, 2014 1:20 PM ET

Biotechnology

Company Overview of Signum Biosciences, Inc.

Executive Profile

Frank LaFerla Ph.D.

Member of Advisory Board, Sonexa Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background

Prof. Frank LaFerla, PhD served as Member of PPM Scientific Advisor at Signum Biosciences, Inc. Dr. LaFerla is the Chancellor's Professor of Neurobiology and Behavior; Director of the Institute for Memory Impairments and Neurological Disorders at the University of California Irvine. He serves as Member of the Advisory Board at Sonexa Therapeutics, Inc. Dr. LaFerla and colleagues developed the triple transgenic (3xTg) mouse model of AD, which has become among the most ...

Corporate Headquarters

7 Deer Park Drive
Monmouth Junction, New Jersey 08852

United States

Phone: 732-329-6344
Fax: 732-329-8344

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Signum Biosciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.